Latest Wheeze Stories
RESEARCH TRIANGLE PARK, N.C., Sept. 22, 2008 (GLOBE NEWSWIRE) -- Icagen, Inc.
A COMMON painkiller may be one of the key driving forces behind the worldwide epidemic of childhood asthma, reveals a major study today.
By TOM VOGT Obesity can aggravate problems in one of the most basic life functions - breathing - according to a study that included some Southwest Washington asthma patients.
By Cydulka, Rita K Asthma is a chronic inflammatory disorder of the airways that affects almost 10% of children, making it the most common chronic disease of childhood. Last year, children with asthma missed an estimated 12.8 million school days due to their disease.
KENILWORTH, N.J., Aug. 19 /PRNewswire-FirstCall/ -- Schering-Plough Corporation announced today that ASMANEX(R) TWISTHALER(R) 110 mcg (mometasone furoate inhalation powder) is now available in pharmacies nationwide.
CHICAGO, Aug. 15 /PRNewswire-USNewswire/ -- As the school bells get ready to ring, parents and other caregivers of children who have asthma should prepare for a possible peak in asthma episodes (also known as attacks or exacerbations).
By HELEN PUTTICK and JULIA HORTON A NEW treatment which could help millions of asthma patients ward off attacks could be tried in patients as early as next year. Research which helps explain why catching a cold triggers symptoms such as wheezing and breathlessness in asthmatics is unveiled today.
By Duplessis, Christopher A Gumpert, Barton ABSTRACT Objective: An observational study was performed with a convenience sample of 38 submariners exposed to diesel exhaust for 9 hours, to assess the development of reactive airways dysfunction syndrome (RADS) after prophylactic corticosteroid treatment.
WASHINGTON, Aug. 4 /PRNewswire-USNewswire/ -- Air pollution is a serious health issue, especially in Beijing.
MONTREAL--(Marketwire - July 23, 2008) - TOPIGEN Pharmaceuticals Inc., a clinical-stage biopharmaceutical company specialized in developing products for respiratory disorders, today announced the completion of patient enrollment in a Phase II safety and efficacy study in asthma with one of its lead product candidates, TPI ASM8.
- A transitional zone between two communities containing the characteristic species of each.